Fluorobenzene

Fluorobenzene

SCHEMBL5865256

Fc1ccccc1.Fc1ccccc1.O=C(O)O.O=C(O)O

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Fluorobenzene. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KCNN4 O15554 3/20 0.48
RAB9A P51151 3/20 0.48
NPC1 O15118 2/20 0.48
CES2 O00748 5/20 0.48
CES1 P23141 5/20 0.48
BCL2L1 Q07817 1/20 0.46
BAD Q92934 1/20 0.46
ALDH1A1 P00352 3/20 0.45
DAO P14920 1/20 0.45
TSHR P16473 1/20 0.45
NAPRT Q6XQN6 1/20 0.45
ALOX15 P16050 1/20 0.45
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
NFE2L2 Q16236 1/20 0.43
HPGD P15428 1/20 0.43
PARP1 P09874 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fluorobenzene SCHEMBL28144868 1.00 KCNN4 (0.48) KCNN4RAB9ANPC1CES2CES1
Fluorobenzene SCHEMBL7243186 0.88 CES2 (0.46) KCNN4RAB9ANPC1CES2CES1
Fluorobenzene SCHEMBL5606691 0.88 CES2 (0.46) KCNN4RAB9ANPC1CES2CES1
Fluorobenzene SCHEMBL28280264 0.88 ALDH1A1 (0.48) KCNN4RAB9ANPC1CES2CES1
Fluorobenzene SCHEMBL10885260 0.88 KCNN4 (0.56) KCNN4RAB9ANPC1CES2CES1
Fluorobenzene SCHEMBL9441778 0.88 ALDH1A1 (0.48) KCNN4RAB9ANPC1CES2CES1
Fluorobenzene SCHEMBL27399872 0.88 KCNN4 (0.56) KCNN4RAB9ANPC1CES2CES1
Fluorobenzene SCHEMBL15544432 0.86 NFE2L2 (0.53) KCNN4RAB9ANPC1ALDH1A1TSHR
Fluorobenzene SCHEMBL14012524 0.86
Fluorobenzene SCHEMBL12363 0.86

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7030138-B2 Benzamidine derivatives SANKYO COMPANY, LIMITED (JP) 2006-04-18 US disclosed
US-20040147555-A1 Benzamidine derivatives SANKYO COMPANY, LIMITED (JP) 2004-07-29 US disclosed
EP-1375482-A1 BENZAMIDINE DERIVATIVE Sankyo Company, Limited (JP) 2004-01-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040147555-A1 Benzamidine derivatives F9, F7, F2 KCNN4 332/4885RAB9A 422/4885NPC1 4266/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.